Potential mechanism for endothelial progenitor cell therapy in acute myocardial infarction: Activation of VEGF- PI3K/AkteNOS pathway

Annals of Clinical and Laboratory Science

Volumn 43, Issue 4, 2013, Pages 395-401

  Cheng, Yan ^a   Jiang, Shisen ^b   Hu, Ruoyu ^c   Lv, Lei ^a,b  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

^c AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Akt; Endothelial progenitor cells; ENOS; Neovascularization; VEGF

Indexed keywords

CELL SURFACE MARKER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; WORTMANNIN; NOS3 PROTEIN, MOUSE; ONCOPROTEIN; VASCULOTROPIN A;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; CELL THERAPY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIAL PROGENITOR CELL; FIBROSING ALVEOLITIS; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE SIZE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; METABOLISM; MYOCARDIAL INFARCTION; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MICE; MYOCARDIAL INFARCTION; NITRIC OXIDE SYNTHASE TYPE III; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84888994011     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Dimmeler S, Zeiher AM. Cell therapy of acute myocardial infarction: open questions. Cardiology 2009;113(3):155-60.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275(5302):964-7.
3. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28(9):1584-95.
4. Schmidt-Lucke C, Fichtlscherer S, Aicher A, Tschope C, Schultheiss HP, Zeiher AM, et al. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PLoS One 2010;5(11):e13790.
5. Sen S, McDonald SP, Coates PT, Bonder CS. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci (Lond) 2011;120(7):263-83.
6. Niessner A, Hohensinner PJ, Rychli K, Neuhold S, Zorn G, Richter B, et al. Prognostic value of apoptosis markers in advanced heart failure patients. Eur Heart J 2009;30(7):789-96.
7. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353(10):999-1007.
8. Sen S, Merchan J, Dean J, Ii M, Gavin M, Silver M, et al. Autologous transplantation of endothelial progenitor cells genetically modified by adeno-associated viral vector delivering insulin-like growth factor-1 gene after myocardial infarction. Hum Gene Ther 2010;21(10):1327-34.
9. Dubois C, Liu X, Claus P, Marsboom G, Pokreisz P, Vandenwijngaert S, et al. Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction. J Am Coll Cardiol 2010;55(20):2232-43.
10. Schuh A, Liehn EA, Sasse A, Hristov M, Sobota R, Kelm M, et al. Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model. Basic Res Cardiol 2008;103(1):69-77.
11. Westenbrink BD, Lipsic E, van der Meer P, van der Harst P, Oeseburg H, Du Marchie Sarvaas GJ, et al. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 2007;28(16):2018-27.
12. Yao Y, Li Y, Ma G, Liu N, Ju S, Jin J, et al. In vivo magnetic resonance imaging of injected endothelial progenitor cells after myocardial infarction in rats. Mol Imaging Biol 2011;13(2):303-13.
13. Dimmeler S, Zeiher AM. Akt takes center stage in angiogenesis signaling. Circ Res 2000;86(1):4-5.
14. Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 2002;90(12):1243-50.
15. Kitamura T, Asai N, Enomoto A, Maeda K, Kato T, Ishida M, et al. Regulation of VEGF-mediated angiogenesis by the Akt/ PKB substrate Girdin. Nat Cell Biol 2008;10(3):329-37.
16. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999;399(6736):601-5.
17. Huang PH, Chen YH, Tsai HY, Chen JS, Wu TC, Lin FY, et al. Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol 2010;30(4):869-77.
18. Liang C, Ren Y, Tan H, He Z, Jiang Q, Wu J, et al. Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products. Br J Pharmacol 2009;158(8):1865-73.
19. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001;108(3):391-7.
20. Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 2010;107(12):1445-53.
21. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasiscorrelation in invasive breast carcinoma. N Engl J Med 1991;324(1):1-8.
22. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004;24(2):288-93.
23. Somanath PR, Razorenova OV, Chen J, Byzova TV. Akt1 in endothelial cell and angiogenesis. Cell Cycle 2006;5(5):512-8.
24. Nakagawa K, Shibata A, Saito T, Sookwong P, Kato S, Tsuduki T, et al. Phosphatidylcholine hydroperoxide promotes VEGFinduced angiogenesis in endothelial cells and rat aorta ring cultures. Biochim Biophys Acta 2011;1810(12):1205-11.
25. Phung TL, Ziv K, Dabydeen D, Eyiah-Mensah G, Riveros M, Perruzzi C, et al. Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell 2006;10(2):159-70.
26. Wipf P, Halter RJ. Chemistry and biology of wortmannin. Organic &biomolecular chemistry. 2005;3:2053-2061.
27. Ii M, Nishimura H, Iwakura A, Wecker A, Eaton E, Asahara T, et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported"nitric oxide synthase activity. Circulation 2005;111(9):1114-20.
28. Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol. 2010;225:631-637.